Old and new oral anticoagulants in the management of atrial fibrillation. Hungarian data
INTRODUCTION: Despite a progress in the management of patients with atrial fibrillation this arrhythmia is one of the major causes of stroke, heart failure, sudden death and cardiovascular morbidity. Oral anticoagulation with vitamin K antagonist or non-vitamin K antagonist markedly reduces stroke and mortality in atrial fibrillation patients.
AIM: To estimate the real-life vitamin K antagonist and non-vitamin K antagonist oral anticoagulant treatment in past years in Hungary.
METHOD: Analysis of the National Health Insurance Administation database for atrial fibrillation (BNO: I48) between 2010-2015. We assumed that AF patient would turn to health care provides at least once either as inpatients or outpatients in a 5-year period. The patient was accepted as adherent after 6 months therapy and at least 80% oral anticoagulant prescription.
RESULTS: The prevalence of AF in Hungary is 3%. The mortality rate of AF 7%-10% per year. The adherence of the old oral anticoagulant treatment was 55%, but it was 69% among patient treated by "new" oral anticoagulant treatment. However, one third of the patients are not treated by effective old or new oral anticoagulant treatment.
CONCLUSIONS: We need more effort to improve the effective and high adherence oral anticoagulant therapy in our country. Orv Hetil. 2017; 158(39): 1545-1549.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2017 |
|---|---|
| Erschienen: |
2017 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:158 |
|---|---|
| Enthalten in: |
Orvosi hetilap - 158(2017), 39 vom: 25. Okt., Seite 1545-1549 |
| Sprache: |
Ungarisch |
|---|
| Weiterer Titel: |
Régi és új orális antikoagulánsok hazai alkalmazása pitvarfibrillációban |
|---|
| Beteiligte Personen: |
Tomcsányi, János [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 07.12.2017 Date Revised 07.12.2017 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1556/650.2017.30802 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM276129083 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM276129083 | ||
| 003 | DE-627 | ||
| 005 | 20231225011307.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2017 xx |||||o 00| ||hun c | ||
| 024 | 7 | |a 10.1556/650.2017.30802 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0920.xml |
| 035 | |a (DE-627)NLM276129083 | ||
| 035 | |a (NLM)28942666 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a hun | ||
| 100 | 1 | |a Tomcsányi, János |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Old and new oral anticoagulants in the management of atrial fibrillation. Hungarian data |
| 246 | 3 | 3 | |a Régi és új orális antikoagulánsok hazai alkalmazása pitvarfibrillációban |
| 264 | 1 | |c 2017 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 07.12.2017 | ||
| 500 | |a Date Revised 07.12.2017 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a INTRODUCTION: Despite a progress in the management of patients with atrial fibrillation this arrhythmia is one of the major causes of stroke, heart failure, sudden death and cardiovascular morbidity. Oral anticoagulation with vitamin K antagonist or non-vitamin K antagonist markedly reduces stroke and mortality in atrial fibrillation patients | ||
| 520 | |a AIM: To estimate the real-life vitamin K antagonist and non-vitamin K antagonist oral anticoagulant treatment in past years in Hungary | ||
| 520 | |a METHOD: Analysis of the National Health Insurance Administation database for atrial fibrillation (BNO: I48) between 2010-2015. We assumed that AF patient would turn to health care provides at least once either as inpatients or outpatients in a 5-year period. The patient was accepted as adherent after 6 months therapy and at least 80% oral anticoagulant prescription | ||
| 520 | |a RESULTS: The prevalence of AF in Hungary is 3%. The mortality rate of AF 7%-10% per year. The adherence of the old oral anticoagulant treatment was 55%, but it was 69% among patient treated by "new" oral anticoagulant treatment. However, one third of the patients are not treated by effective old or new oral anticoagulant treatment | ||
| 520 | |a CONCLUSIONS: We need more effort to improve the effective and high adherence oral anticoagulant therapy in our country. Orv Hetil. 2017; 158(39): 1545-1549 | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a K-vitamin-antagonista | |
| 650 | 4 | |a adherence | |
| 650 | 4 | |a adherencia | |
| 650 | 4 | |a anticoagulation | |
| 650 | 4 | |a antikoaguláció | |
| 650 | 4 | |a atrial fibrillation | |
| 650 | 4 | |a non-vitamin K antagonist | |
| 650 | 4 | |a pitvarfibrilláció | |
| 650 | 4 | |a prevalence | |
| 650 | 4 | |a vitamin K antagonists | |
| 650 | 4 | |a új orális nem K-vitamin-antagonista | |
| 650 | 7 | |a Anticoagulants |2 NLM | |
| 650 | 7 | |a Fibrinolytic Agents |2 NLM | |
| 700 | 1 | |a Salfer, Balázs |e verfasserin |4 aut | |
| 700 | 1 | |a Nagy, Bence |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Orvosi hetilap |d 1949 |g 158(2017), 39 vom: 25. Okt., Seite 1545-1549 |w (DE-627)NLM000021601 |x 1788-6120 |7 nnns |
| 773 | 1 | 8 | |g volume:158 |g year:2017 |g number:39 |g day:25 |g month:10 |g pages:1545-1549 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1556/650.2017.30802 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 158 |j 2017 |e 39 |b 25 |c 10 |h 1545-1549 | ||